Women are dying needlessly from a disease medicine now knows how to treat
In Northern Ireland, coronary heart disease quietly claims the lives of more than twice as many women each year as breast cancer does, yet it persists in the collective imagination as a man's affliction. Women arrive late to diagnosis, are more often misread by the systems meant to protect them, and leave hospital with fewer of the medicines that might keep them alive. This is not merely a gap in knowledge — it is a gap in care, shaped by decades of research that centred the male body as the medical default, and it is costing women their lives.
- Coronary heart disease kills around 1,600 people in Northern Ireland every year, and women — widely assumed to be at lower risk — are dying from it at rates that dwarf breast cancer fatalities.
- Women experiencing heart attacks frequently misread their own symptoms, waiting precious hours before seeking help, while the healthcare system compounds the delay by misdiagnosing them at a rate 50% higher than men.
- Even after surviving a cardiac event, women are less likely to be prescribed the preventive medications that reduce the risk of a second, potentially fatal attack — a disparity that suggests the bias does not end at the emergency room door.
- Post-menopausal hormonal shifts quietly erode the cardiovascular protection women once had, yet most remain unaware of this change in their risk profile and rarely attend the health checks that could catch danger early.
- The British Heart Foundation is calling for women over 40 to seek cardiovascular checks every five years and for the medical system itself to close the treatment gap — because awareness campaigns alone cannot save lives if the care women receive remains unequal.
In Northern Ireland, coronary heart disease kills more than twice as many women each year as breast cancer — yet it remains stubbornly perceived as a man's condition. Heart and circulatory diseases account for roughly a quarter of all deaths in the region, with coronary heart disease alone claiming around 1,600 lives annually. Globally, it is the leading killer of women. Awareness, however, has not kept pace with the reality.
A British Heart Foundation briefing has laid out the scale of what researchers call the gender gap in heart disease care. Women having heart attacks often fail to recognise their own symptoms and delay seeking help. When they do arrive for treatment, they face a 50 percent higher chance of an incorrect initial diagnosis than men. They are less likely to receive time-sensitive interventions, and after surviving a heart attack, they are prescribed preventive medications at lower rates — leaving them more exposed to a second event.
Biology is part of the story. Before menopause, oestrogen offers a degree of protection to cholesterol levels and artery walls. As that hormonal shield fades, coronary arteries narrow more readily and risk rises — yet many women remain unaware of this shift and do not attend regular health checks. Symptoms, too, can be ambiguous: chest discomfort, pain radiating to the arm, jaw or stomach, nausea, breathlessness. A woman might attribute these to stress or indigestion and wait, or call a friend rather than an ambulance.
The British Heart Foundation recommends that women over forty see a GP or practice nurse at least every five years for a cardiovascular check, with blood pressure and cholesterol measured and family history disclosed. But the briefing is clear that individual awareness is not sufficient. The system itself must change — delivering to women the same speed of diagnosis and quality of treatment that men receive. Until it does, women will continue to die from a disease that medicine already knows how to treat.
In Northern Ireland, coronary heart disease kills more than twice as many women each year as breast cancer does. Yet the disease remains stubbornly coded in the public mind as a man's problem. The numbers tell a different story. Heart and circulatory diseases account for a quarter of all deaths in the region—roughly 4,000 people annually, or eleven every single day. Coronary heart disease alone claims around 1,600 lives per year, averaging four deaths daily. Globally, it is the leading killer of women. But awareness lags dangerously behind the reality.
A recent briefing from the British Heart Foundation has documented what researchers call the gender gap in heart disease care, and the findings are stark. Women having heart attacks wait longer before seeking help because they simply don't recognize what's happening to their bodies. When they do arrive for treatment, they face a 50 percent higher chance of receiving an incorrect initial diagnosis than men do. Once admitted, they are less likely to receive time-sensitive, potentially life-saving treatments. And after surviving a heart attack, women are prescribed preventive medications at lower rates than their male counterparts—leaving them more vulnerable to a second, potentially fatal event.
Dr. Sonya Babu-Narayan, Associate Medical Director at the British Heart Foundation, put it plainly: decades of medical research have transformed outcomes for heart attack patients, but if you are a woman, the odds work against you. The gap is not accidental. It reflects both biology and bias—a combination that costs lives.
Biology plays a role. Before menopause, women benefit from estrogen's protective effect on cholesterol and artery walls, which lowers their baseline risk. But as estrogen production declines during and after menopause, that shield diminishes. Coronary arteries narrow more easily. The risk climbs. Yet many women remain unaware of this shift in their vulnerability, and many do not pursue regular health checks to catch problems early. The result is a population dramatically underestimating its own danger.
The standard risk factors apply: high blood pressure, elevated cholesterol, smoking, diabetes, excess weight, sedentary living. But women often don't know to watch for them with the same vigilance men do. Heart attack symptoms themselves can be ambiguous—chest pain or discomfort that arrives suddenly and won't fade, pain radiating into the arm or neck or jaw or stomach, nausea, sweating, lightheadedness, breathlessness. A woman might attribute these to stress or indigestion. She might wait. She might call a friend instead of an ambulance.
The British Heart Foundation recommends that all women over forty visit their GP or practice nurse at least once every five years for a cardiovascular health check. Blood pressure and cholesterol should be measured. Family history matters: if a father or brother received a diagnosis before age fifty-five, or a mother or sister before sixty-five, that history should be disclosed to a doctor. These conversations can identify risk before crisis strikes.
But the briefing makes clear that awareness alone is not enough. The system itself must change. Women must not only know their risk; they must receive the same quality of care, the same speed of diagnosis, the same access to treatment that men receive. Until that happens, women will continue to die needlessly from a disease that medicine now knows how to treat—if only the treatment arrives in time.
Notable Quotes
If you are a woman, the odds are stacked differently— Dr. Sonya Babu-Narayan, Associate Medical Director, British Heart Foundation
Women may be dramatically underestimating their personal risk of heart attack due to lack of awareness and low uptake of health checks— British Heart Foundation briefing
The Hearth Conversation Another angle on the story
Why does heart disease get coded as a man's disease when it kills more women than breast cancer?
Because for decades, research focused on men. The classic heart attack—the sudden chest pain, the dramatic collapse—was studied in male bodies. Women's symptoms are often subtler, more diffuse. A woman might feel nauseous or short of breath and not connect it to her heart. Doctors, trained on male presentations, miss it too.
So it's a problem of recognition, not biology?
Both. Biology matters—estrogen does protect women before menopause. But recognition is the killer. A woman delays calling for help because she doesn't think it's a heart attack. By the time she arrives at hospital, she's already lost time. Then she gets misdiagnosed half again as often as a man would be.
What happens after the misdiagnosis?
She goes home. Or she gets admitted but doesn't receive the same treatments a man would. Medications that prevent second attacks are prescribed less often to women. The system fails her twice.
Is this about individual doctors being biased, or something structural?
Both again. Individual bias exists—unconscious, but real. But it's also structural. Medical training, protocols, even the way symptoms are described in textbooks—all of it was built on male bodies as the default. Women have to fit into a template designed for someone else.
What would change it?
Awareness helps, but it's not enough. Women need to know their risk, yes. But doctors need retraining. Protocols need updating. And the system needs to move faster for women, not slower. Right now, a woman having a heart attack is already behind.
So the recommendation to get checked every five years—is that enough?
It's a start. But only if those checks actually happen, and only if the results are taken seriously. Many women still don't go. And even when they do, the information doesn't always change behavior or clinical practice. The gap persists.